Plant growth retardants (PGRs) reduce the shoot growth of plants by inhibiting gibberellin biosynthesis. In this study, we performed detailed analyses of the inhibitory effects of PGRs on Arabidopsis abscisic acid (ABA) 8 0 -hydroxylase, a major ABA catabolic enzyme, recently identified as CYP707As. In an in vitro assay with CYP707A3 microsomes expressed in insect cells, uniconazole-P inhibited CYP707A3 activity more effectively than paclobutrazol or tetcyclacis, whereas the other PGRs tested did not inhibit it significantly. Uniconazole-P was found to be a strong competitive inhibitor (K i ¼ 8:0 nM) of ABA 8 0 -hydroxylase. Uniconazole-P-treated Arabidopsis plants showed enhanced drought tolerance. In uniconazole-P-treated plants, endogenous ABA levels increased 2-fold as compared with the control, and co-application of GA 4 did not suppress the effects, indicating that the effects were not due to gibberellin deficiency. Thus uniconazole-P effectively inhibits ABA catabolism in Arabidopsis plants. We also discuss the structure-activity relationship of the azole-type compounds on ABA 8 0 -hydroxylase inhibitory activity.
Plant growth retardants (PGRs) reduce the shoot growth of plants by inhibiting gibberellin biosynthesis. In this study, we performed detailed analyses of the inhibitory effects of PGRs on Arabidopsis abscisic acid (ABA) 8 0 -hydroxylase, a major ABA catabolic enzyme, recently identified as CYP707As. In an in vitro assay with CYP707A3 microsomes expressed in insect cells, uniconazole-P inhibited CYP707A3 activity more effectively than paclobutrazol or tetcyclacis, whereas the other PGRs tested did not inhibit it significantly. Uniconazole-P was found to be a strong competitive inhibitor (K i ¼ 8:0 nM) of ABA 8 0 -hydroxylase. Uniconazole-P-treated Arabidopsis plants showed enhanced drought tolerance. In uniconazole-P-treated plants, endogenous ABA levels increased 2-fold as compared with the control, and co-application of GA 4 did not suppress the effects, indicating that the effects were not due to gibberellin deficiency. Thus uniconazole-P effectively inhibits ABA catabolism in Arabidopsis plants. We also discuss the structure-activity relationship of the azole-type compounds on ABA 8 0 -hydroxylase inhibitory activity.
Key words: abscisic acid; cytochrome P450; plant growth retardant; uniconazole; drought tolerance A plant hormone, abscisic acid (ABA), regulates many important physiological processes including seed development, seed dormancy, and adaptive responses to abiotic stresses. 1) For correct activity, physiologically active ABA levels are controlled through de novo biosynthesis and catabolism. There are several metabolic pathways by which ABA can be removed or degraded in plant tissues. The main route involves hydroxylation of the C-8 0 position of ABA, spontaneous rearrangement of the resulting 8 0 -hydroxy-ABA (8 0 -OH-ABA) to form phaseic acid (PA), and reduction to dihydrophaseic acid (DPA) (Fig. 1) .
2) Several investigations using ABA analogs resistant to metabolism at the 8 0 -carbon atom have confirmed that hydroxylation at the C-8 0 position of ABA plays an important role in controlling ABAmediated effects. 3, 4) Thus (+)-ABA 8 0 -hydroxylase is considered the pivotal enzyme in controlling the degradation rate of ABA. 2) Recently, the CYP707A family of cytochromes P450 (P450s) has been found to encode (+)-ABA 8 0 -hydroxylase of Arabidopsis thaliana. 5, 6) Because the CYP707A family plays a key regulatory role in controlling the level of ABA in plants, chemical inhibitors specific to CYP707A should be good tools to manipulate the endogenous level of ABA and to understand the physiological roles of ABA in plants.
Compounds with a nitrogen-containing heterocycle, such as triazoles and imidazoles, are known to act as inhibitors of various P450-dependent reactions. Among them, several compounds, including pyrimidine ancymidol, a norbornanodiazetine derivative, tetcyclacis, and the triazole-type compounds, uniconazole and paclobutrazol, are utilized as plant growth retardants (PGRs).
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y To whom correspondence should be addressed. Fax: +81-774-38-3229; E-mail: mizutani@scl.kyoto-u.ac.jp Abbreviations: ABA, abscisic acid; BR, brassinosteroid; DPA, dihydrophaseic acid; 8 0 -OH-ABA, 8 0 -hydroxyabscisic acid; GA, gibberellin; GC-EIMS, gas chromatography-electron impact ionization mass spectrometry; NCED, 9-cis-epoxycarotenoid dioxygenase; PA, phaseic acid; P450, cytochrome P450; PGR, plant growth retardant These growth regulators inhibit P450 ent-kaurene oxidase (CYP701), catalyzing the oxidation of entkaurene to ent-kaurenoic acid in gibberellin (GA) biosynthesis. 8, 9) Alternatively, uniconazole is shown to block the oxidation of campestanol to 6-deoxocathasterone catalyzed by DWF4 in brassinosteroid (BR) biosynthesis. 10) In addition, there are many reports stating that treatment with these inhibitors alters the levels of phytosterols, phenylpropanoids, polyamines, and other hormones, such as auxins, cytokinins, ethylene, jasmonate, and ABA. Nevertheless, it remains unknown whether this is due to direct inhibition of various other P450s or to the indirect effect of changes in GA or BR levels.
The application of many P450 inhibitors has been shown to enhance the stress tolerance of plants. 11) Such inhibitor treatment often causes alteration of endogenous ABA levels, although this depends on the plant species, organ, and developmental stage. 7) Generally, ABA levels increase within a short period after inhibitor application.
12) The mechanism by which P450 inhibitors cause ABA accumulation has been extensively studied in tetcyclacis. Radiotracer experiments demonstrate that the conversion of ABA to PA is impaired in tetcyclacistreated plants. [12] [13] [14] Moreover, tetcyclacis has been shown to inhibit the ABA 8 0 -hydroxylase activity of the microsomal fraction from maize suspension cells 15) or from yeast heterologously expressing Arabidopsis CYP707A1. 5) Recent cloning of CYP707A has enabled us to examine the biochemical nature of these P450 inhibitors blocking ABA 8 0 -hydroxylase activity. Recently, Kitahata et al. (2005) screened nine known triazole-type compounds by testing inhibition of the conversion of ABA to PA in cultured tobacco BrightYellow-2 cells. 16) They found that uniconazole-P significantly inhibited the conversion in Bright Yellow-2 cells, and also found in a structure activity study of uniconazole-P that a fungicide diniconazole is a more effective inhibitor than uniconazole-P. Furthermore, diniconazole showed strong inhibitory activity for ABA 8 0 -hydroxylase in an in vitro assay using recombinant Arabidopsis CYP707A3, and diniconazole-treated plants showed increased levels of endogenous ABA and more drought-stress tolerance than untreated plants. These results indicate that diniconazole is a potent inhibitor of ABA catabolism. Although uniconazole-P was also found to inhibit the conversion of ABA to PA in Bright Yellow-2 cells, its inhibitory activity on ABA 8 0 -hydroxylase in vitro and in vivo has not been characterized yet. Because PGRs are important chemicals applied in agriculture and utilized as a GA biosynthesis inhibitor in basic plant science, the effects of PGRs on ABA catabolism should be investigated in detail. In this paper, we report detailed characterization of the inhibitory effects on Arabidopsis ABA 8 0 -hydroxylase of several inhibitors known as PGRs. Both in vitro and in vivo experiments showed that uniconazole-P inhibits ABA 8 0 -hydroxylase activity more effectively than the other PGRs examined. Based on these results, we also discuss the structure-activity relationship of azole-type inhibitors on ABA 8 0 -hydroxylase inhibitory activity.
Materials and Methods
Instruments. UV spectra were measured with an SPD-10A VP instrument (Shimadzu, Kyoto, Japan). Electron impact ionization mass spectrometry (EIMS) measurements were carried out with a JEOL JMS-Automass SUN (Tokyo).
Chemicals. (+)-ABA was purchased from BAL Planning (Aichi, Japan). Chlormequat-Cl, daminozide, and compounds with a nitrogen-containing heterocycle were purchased from Wako Pure Chemical Industries (Osaka, Japan), except for brassinazole and tetcyclacis, which were kindly provided by Dr. T. Asami (RIKEN, Saitama, Japan). PA was prepared by hydrolysis of the -hydroxy--methylglutaryl ester of 8 0 -OH-ABA isolated from immature seeds of Robinia pseudo-acacia, as described previously. 17) Plant materials. The plants used in this study were Arabidopsis thaliana (L.) Heynh of ecotype Columbia. They were grown in pots containing a 1:1 mixture of vermiculite-Jiffy mix (Sakata Seed, Kanagawa, Japan) under continuous light conditions at 22 C. For inhibition of PA production by various concentrations of P450 inhibitors, 2-week-old plants grown on 1% agar plates containing 1/2 MS salts were incubated with the indicated concentrations of inhibitors with 30 mM (+)-ABA solution for 3 h. The plant materials were frozen at À80 C for GC-EIMS analysis. For kinetic analysis of the inhibition of PA production by P450 inhibitors, 2-week-old plants were subjected to 30 mM (+)-ABA solution with 25 mM of paclobutrazol, 25 mM of unico- nazole-P, or water as a control during the indicated time periods. The plant materials were frozen at À80 C for GC-EIMS analysis. To confirm the effects of P450 inhibitors on drought tolerance, 34-d-old plants were sprayed evenly three times with either 50 mM of paclobutrazol, 50 mM of uniconazole-P, or water as a control over 10 d (approximately 30 ml of each solution per 16 plants). The plants received no water for 10 d, except for the three-time misting. After withholding of water, the plants were fully irrigated to measure the survival rate. To measure water loss caused by transpiration, weights of detached rosette leaves were monitored. Thirty-d-old plants were sprayed uniformly with 50 mM of uniconazole-P, 50 mM of uniconazole-P containing 5 mM of GA 4 solution, or water as a control (approximately 5 ml of each solution per 12 plants), and incubated for 12 h to evaporate the solution on the plants. After incubation, the weight of the detached rosette leaves was measured and the rate of water loss was calculated from their weights. For analysis of endogenous levels of ABA and PA under drought stress, 2-week-old plants grown on 1% agar plates containing 1/2 MS salts and 50 mM of uniconazole-P, 50 mM of uniconazole-P containing 5 mM of GA 4 solution, or water as a control, were incubated. After 6 h of incubation, the plants were transferred onto dried filter paper and incubated under continuous light conditions at 22 C for 6 h without sealing. The plant materials were frozen at À80 C for GC-EIMS analysis.
Quantitative analysis of endogenous ABA and PA. Measurement of endogenous ABA and PA were described elsewhere. 5, 18) Briefly, plant materials (0.5 to 1 g) were homogenized in 80% (v/v) acetone containing 0.1 mg/ml 2,6-di-tert-butyl-4-methylphenol as an antioxidant. After adding 13 C-ABA and PA-d 3 as internal standards, the homogenate was shaken for 1 h on ice in darkness and then centrifuged at 1,200 g for 10 min at 4 C. The supernatant was evaporated to remove acetone, and the residual aqueous solution was extracted with hexane at pH 2, and the residual aqueous solution was reextracted with ethyl acetate. The organic layers were combined and concentrated to give methanolsoluble materials. The materials were dissolved in 110 ml of 10% (v/v) aq. methanol containing 0.1% (v/v) acetic acid, and subjected to HPLC equipped with a PEGASIL-B column (Senshu Scientific, ODS, 250-mm length Â 4.6-mm i.d.) under the following gradient conditions at room temperature: (A) 10% (v/v) aq. methanol containing 0.1% (v/v) acetic acid, (B) 60% aq. methanol containing 0.1% (v/v) acetic acid, 0-3 min 50% B, 3-33 min 50-100% B linear gradient; flow rate 1.0 ml/ min; detection at 254 nm. Retention times for PA and ABA were 16 and 30 min respectively. The ABA fraction was methylated with diazomethane, while the PA fraction was trimethylsilylated with N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) at 60 C for 10 min. The following m=z peaks were used for quantification: for ABA, 192 (labeled) and 190 (endogenous); for PA, 265 (deuterated) and 262 (endogenous). Backup ions (labeled ABA 262 and 163; endogenous ABA 260 and 162; deuterated PA 355, 328, and 306; endogenous PA 352, 325, and 303) were also monitored for peak confirmation.
Microsomal assay. The preparation of recombinant CYP707A3 microsomes using a baculovirus-insect cell system was described elsewhere. 6) A typical incubation contained 50 mM potassium phosphate (pH 7.25), 25 mg/ ml recombinant CYP707A3 microsomes, and (+)-ABA. Reactions were initiated by the addition of NADPH to a final concentration of 100 mM, carried out at 30 C for 10 min, and stopped by the addition of 100 ml of 1 N HCl. For relative inhibitory activity, 5 mM of (+)-ABA and 10 mM of each inhibitor were incubated. For determination of IC 50 values, 5 mM (+)-ABA and concentrations of inhibitors (0-4 mM for paclobutrazol, 0.05-1 mM for tetcyclacis, and 0-100 nM for uniconazole-P) were incubated with the microsomes. IC 50 values were determined by plotting the initial velocity (v 0 ) versus the inhibitor concentration. For determination of a K i value, 0.5, 1.0, or 2.0 mM of (+)-ABA and concentrations of uniconazole-P (ranging from 1 to 32 nM) were incubated with the microsomes. The K i value was determined by a Dixon plot of the v 0 versus the inhibitor concentration. The kinetic constants were calculated from triplicate data sets. The reaction products were measured by HPLC, as described previously. 6) Computational methods. The minimum-energy conformers of (+)-ABA, uniconazole and paclobutrazol, were generated using CAChe 3.11 19) or GaussView with Gaussian 03, 20) and minimized using MM3 built into the software. The overlaid structures of these compounds were obtained by the overlay method built into Chem 3D.
21)

Results and Discussion
Inhibitory activity of plant growth retardants on ABA 8 0 -hydroxylase in vitro Several known compounds for PGRs were investigated to characterize their inhibitory effects on Arabidopsis ABA 8 0 -hydroxylase in vitro (Fig. 2) . The Arabidopsis CYP707A family consists of four genes, CYP707A1, A2, A3, and A4, and all CYP707A proteins have been confirmed to function as ABA 8 0 -hydroxylase by their heterologous expression in yeast 5) and insect cells.
6) Recombinant CYP707A3 protein was highly and stably expressed in insect cells, and the kinetic parameters (K m and k cat ) for the substrate (+)-ABA were determined to be 1.3 mM and 15 min À1 respectively. 6) Therefore, in order to investigate the inhibitory activity of PGRs against ABA 8 0 -hydroxylase, we used CYP707A3 microsomes prepared from insect cells expressing CYP707A3 in our in vitro assay. Chlorme-quat-Cl and daminozide are non-azole PGRs, and they inhibit ent-copalyl diphosphate synthase and 2-oxoglutarate dependent dioxygenase in GA biosynthesis respectively. 7) Ancymidol, inabenfide, paclobutrazol, and uniconazole-P are known to inhibit CYP701 activity, catalyzing the oxidation of ent-kaurene to ent-kaurenoic acid in GA biosynthesis. 7) A norbornanodiazetine-type inhibitor, tetcyclacis, known as a GA biosynthesis inhibitor, is also used as an ABA catabolism inhibitor. 7) Brassinazole is a triazole inhibitor specific to BR biosynthesis, and it inhibits C-22 hydroxylation by DWF4 (CYP90B1). 10) Tebuconazole is a triazole-type fungicide targeting sterol biosynthesis that inhibits sterol 14-demethylases (CYP51s).
22) The latter two compounds were used as reference compounds of P450 inhibitors not belonging to PGRs. Each compound was incubated in the presence of 5 mM (+)-ABA in the in vitro assay with CYP707A3 microsomes, and the relative inhibitory activity was determined (Fig. 3) . Brassinazole and tebuconazole did not inhibit this activity. Among PGRs, non-azole compounds, ancymidol, and inabenfide did not inhibit CYP707A3 activity significantly. In contrast, paclobutrazol and tetcyclacis inhibited PA formation by more than 70% in the assay conditions, and uniconazole-P at 10 mM inhibited the activity of ABA 8 0 -hydroxylase almost completely. The IC 50 values (concentrations of the inhibitor resulting in 50% inhibition) of paclobutrazol, tetcyclacis, and uniconazole-P were determined to be 3,000, 370, and 68 nM respectively under 5 mM (+)-ABA (Table 1) . It is noteworthy that the IC 50 value of uniconazole-P was more than 5 times lower than that of tetcyclacis, known as an ABA catabolism inhibitor. Ancymidol, chlormequat-Cl, daminozide, inabenfide, paclobutrazol, and uniconazole-P are GA biosynthesis inhibitors. Brassinazole and tebuconazole are a BR biosynthesis inhibitor and a fungicide respectively. Tetcyclacis inhibits both GA biosynthesis and ABA catabolism. The inhibitory activity of uniconazole-P was 44 times stronger than that of paclobutrazol in comparison with the IC 50 values, although the chemical structures of these compounds are closely related (Fig. 2) . Commercially available paclobutrazol contains only two enantiomers, (2S,3S) and (2R,3R), among four optically active forms. 23) The (2S,3S) form exhibits more pronounced plant growth-regulatory activity, whereas the (2R,3R) enantiomer is more active in inhibiting sterol biosynthesis.
9,23) It could not be confirmed whether either (or both) enantiomer(s) inhibited CYP707A activity in this study, but it was clear that the effect of paclobutrazol on Arabidopsis CYP707A3 activity was much less than that of uniconazole-P.
Dixon plot analysis of the inhibition showed that uniconazole-P is a competitive inhibitor of ABA 8 0 -hydroxylase (Fig. 4) . As expected, a type II difference spectrum was also observed, with a trough at 389 nm and a peak at 425 nm, when uniconazole-P was added to CYP707A3 microsomes (data not shown). This indicates that the triazole moiety of the inhibitor binds to the active site by coordination with an iron atom in P450. The K i value was also determined to be 8.0 nM (Fig. 4) . Thus uniconazole-P is a potent competitive inhibitor of Arabidopsis ABA 8 0 -hydroxylase.
Effects of uniconazole-P in vivo Uniconazole-P blocks ABA 8 0 -hydroxylase effectively in vitro, and is therefore expected to inhibit ABA catabolism in vivo. To investigate whether uniconazole-P effectively blocks ABA 8 0 -hydroxylase activity in vivo, PA production was measured for Arabidopsis plants supplied with both 30 mM (+)-ABA and various concentrations of the P450 inhibitor. Application of 0.5 mM uniconazole-P inhibited 50% of PA production as compared to that without the inhibitor (Fig. 5A) . When uniconazole-P was applied at concentrations of more than 5 mM, PA production was inhibited up to one quarter. Kinetic analysis of PA production indicated that inhibition by 25 mM uniconazole-P was observed 1.5 h after treatment (Fig. 5B) . In contrast, application of 25 mM paclobutrazol or tebuconazole did not affect PA production (Fig. 5A, B) . Next, we examined whether inhibition of ABA 8 0 -hydroxylase by uniconazole-P affects drought tolerance. Uniconazole-P-treated Arabidopsis plants showed remarkable drought tolerance, whereas only slight enhancement was observed in the paclobutrazol-treated plants (Fig. 5C) . Furthermore, we examined transpirational water loss and endogenous ABA level in both uniconazole-P-treated and control plants under drought conditions. The rate of water loss was significantly smaller in uniconazole-P-treated leaves than in the control leaves (Fig. 6A) . Consistent with the reduced water loss, the endogenous level of ABA in plants treated with uniconazole-P increased nearly 2-fold, and the amount of PA decreased to about one third as compared with the control value (Fig. 6B) . It is unlikely that these effects are due to GA deficiency caused by the uniconazole-P treatment, because coapplication of GA 4 with uniconazole-P did not suppress them (Fig. 6A, B) . This indicates that the accumulation of endogenous ABA and the decrease in PA levels depended on the inhibition of ABA 8 0 -hydroxylase by uniconazole-P and was not a side effect of inhibitory activity against ent-kaurene oxidase.
Previous studies have also reported increased endogenous ABA levels with triazole compounds such as uniconazole, paclobutrazol, BAS111..W, and tetraconazole in various plant species. 14, [24] [25] [26] [27] [28] In addition, triazoletype growth retardants are effective in protecting plants from various environmental stresses. 11) These results are fully consistent with our observations, suggesting that the CYP707A family ubiquitously regulates endogenous ABA levels in higher plants. Although several catabolic pathways other than 8 0 -hydroxylation contribute to regulate endogenous ABA levels, particularly physiological processes, the significant accumulation of ABA in uniconazole-P-treated plants suggests that the oxidative inactivation pathway via ABA 8 0 -hydroxylation is the major pathway of ABA breakdown under drought stress conditions.
Our results show that the short-term (12 h) effect of uniconazole-P on ABA accumulation is independent of the co-application of GA, suggesting that its effect is due to direct inhibition of CYP707A activity. However, most previous studies have shown a long-term (several weeks) effect of triazole treatment on ABA accumulation. It is possible, then, that the long-term effect of inhibitors is more complicated. It is noteworthy that Arabidopsis CYP707A3 expression is induced by the application of GA or BR; 6) indeed, PA production is induced by GA application in lettuce seeds. 29) Moreover, a negative role of GA in the acquisition of stress tolerance has been suggested. 30) Hence the improved stress tolerance with triazole treatment reported in a number of plant species might be a consequence of inhibited CYP707A activity and pleiotropism.
Accumulation of endogenous ABA is expected to enhance stress tolerance in crop plants, and there have been several attempts to manipulate ABA levels in plants. Plants have enhanced desiccation tolerance when the NCED gene, which encodes the regulatory enzyme of ABA biosynthesis, is overexpressed, 31, 32) but this leads to significant accumulation of the major ABA catabolite, PA, as compared with ABA.
31) The biological activity of ABA is inactivated in a stepwise manner by oxidative catabolism in plants. 33) Hence inhibition of ABA 8 0 -hydroxylase activity appears to be the most effective way to block ABA degradation, resulting in ABA accumulation. The application of ABA results in increased tolerance to a variety of stresses, but, since the transcript levels of all four CYP707A genes are up- A, Effects of uniconazole-P on transpirational water loss. Thirtyd-old plants were sprayed uniformly with 50 mM uniconazole-P ( ) or 50 mM uniconazole-P containing 5 mM GA 4 ( ) solution, or water ( ) as a control, and incubated for 12 h. After incubation, the weights of the detached rosette leaves were measured and the rate of water loss was calculated from the weight. The results are presented as the average with standard errors (n ¼ 12). B, Effects of uniconazole-P on endogenous levels of ABA and PA. Two-weekold plants were incubated with 50 mM uniconazole-P or 50 mM uniconazole-P containing 5 mM GA 4 solution, or water as a control. After 6 h of incubation, the plants were transferred onto dried filter paper and incubated under continuous light conditions at 22 C for 6 h without sealing. Triplicate experiments were performed, and the averages are shown with standard errors. regulated by ABA and various stresses, 6 ) the effects of ABA do not persist. Hence P450 inhibitors specific to ABA 8 0 -hydroxylase are a good tool to manipulate endogenous ABA levels, and can enhance tolerance to various stresses and other ABA-mediated processes in plants.
Structure-activity relationship of azole-type inhibitors on ABA 8 0 -hydroxylase inhibitory activity We found that uniconazole-P strongly inhibits ABA 8 0 -hydroxylase in both in vitro and in vivo assays. Uniconazole-P is a potent competitive inhibitor (K i ¼ 8 nM) of CYP707A3 activity, meaning that the affinity of this inhibitor for ABA 8 0 -hydroxylase active site is more than 100-fold stronger than that of ABA (K m ¼ 1:3 mM).
6) Kitahata et al. (2005) reported the effect of known P450 inhibitors on ABA catabolism in cultured tobacco Bright Yellow-2 cells, and found that a fungicide, S-(+)-diniconazole, more strongly inhibits ABA 8 0 -hydroxylase than uniconazole-P by a factor of 4 based on the K i values, whereas none of the structural uniconazole derivatives tested functioned as an inhibitor. 16) Because the triazole compounds competitively bind to the substrate recognition site of ABA 8 0 -hydroxylase, comparison of their 3-D structures with that of ABA might indicate the reason for the difference in their inhibitory activities.
The geometric properties of triazole compounds with the 4-chlorophenyl group, which were tested in our and Kitahata's studies, 16) are summarized in Table 2 . We defined two parameters, length and width, to represent the geometric properties, as depicted in Fig. 7 . Uniconazole-P, (+)-diniconazole, and tetcyclacis, all of which act as enzyme inhibitors, have quite similar geometric properties; the lengths are about 8.7 Å , and the widths are about 3.2 Å . These widths are consistent with that of ABA, whereas the lengths are longer than that of ABA by 1.2 Å . Figure 8 shows the overlaid structures of four triazole compounds and ABA. First we constructed an overlaid structure of uniconazole-P on ABA. Because the triazole moiety coordinates to the heme iron of the enzyme active site, it should be located near the 8 0 -methyl of ABA. In addition, we shifted triazole sp 2 nitrogen below the 8 0 -hydrogens of ABA, considering that 8 0 -hydrogen interacts with the activated oxygen bound to heme iron, whereas the nitrogen of triazole compounds coordinates directly to heme iron. In this case, the 4-chlorophenyl ring of uniconazole-P is well stacked against the side chain of ABA, and tertbutyl imitates the geminal methyls of ABA, although not perfectly. Therefore, if 4-chlorophenyl mimics the dienecarboxylate side chain of ABA, the length of the tirazole-containing inhibitor should be longer than that of ABA by one bond length or so.
The 3D-structure of uniconazole-P is quite similar to that of diniconazole, which has a 2,4-dichlorophenyl group instead of the 4-chlorophenyl group in uniconazole-P. The stronger activity of (+)-diniconazole as compared with uniconazole-P might result from an additional electrostatic interaction with the active site of ABA 8 0 -hydroxylase through the additional chlorine, which is a better structural mimic of the carboxylate oxygens of ABA. Kitahata et al. demonstrated that replacement of the chlorine of uniconazole-P by nbutoxy, fluorine, methyl, nitrile, or methoxy substantially reduces inhibitory activity. 16) These substituents, The parameter ''length'' is the distance between the 4-nitrogen of triazole (or the farthest sp 2 nitrogen from chlorophenyl) and the 4-carbon of chlorophenyl for azole compounds, and the distance between C-8 0 and C-1 for ABA. The parameter ''width'' is the distance of a plane containing the farthest atoms from a plane containing the chlorophenyl for azole compounds, and the distance of a plane containing the 9 0 -hydrogens from a plane containing the side chain for ABA. The molecules are depicted as sticks. Carbons, hydrogens, nitrogens, oxygens, and chlorines are colored gray, white, blue, red, and light green respectively. except for fluorine, might be too bulky to mimic the carboxylate oxygens in the active site. For fluorine, which is smaller than chlorine, the greater electronegativity and lower polarisability over oxygen and chlorine can result in poorer electrostatic interactions. Table 2 and Fig. 8 can give an explanation as to why the other triazole compounds tested does not act as inhibitors. The geometry of the (Z)-isomer of (+)-diniconazole does not allow the chlorophenyl ring to place the space corresponding to the ABA carboxylate side chain. Paclobutrazol cannot position the triazole to the same plane as the 4-chlorophenyl group owing to the divided conjugation. This difference results in the steric bulkiness of molecules. Considering that even the small enlargement of C-8 0 and C-9 0 significantly reduces affinity to the active site, 34) paclobutrazol might be too bulky to fit into the active site cavity of ABA 8 0 -hydroxylase. Tebuconazole and inabenfide appear to be too long, whereas brassinazole might be too short. These findings suggest that cooperative interactions of the three structural parts, a triazole, chlorophenyl ring, and the other lipophilic parts to the active site are closely optimized in uniconazole-P and (+)-diniconazole.
Uniconazole-P is a well-known PGR and evidently inhibits GA biosynthesis, and BR biosynthesis is also inhibited to some extent, 35) clearly implying that this compound is not specific for ABA catabolism. In order to develop triazole-type inhibitors targeting ABA 8 0 -hydroxylase, it is necessary to improve the specificity of the inhibitors without lowering sensitivity to ABA 8 0 -hydroxylase. Brassinazole, a triazole-type inhibitor specific to BR biosynthesis, was designed based on its homology to uniconazole and paclobutrazol, and was developed by the systematic modification of functional groups attached to the triazole moiety of uniconazole. 36) In the same way, it should be possible to design and synthesize a more potent and specific inhibitor of ABA 8 0 -hydroxylase based on the chemical structure of uniconazole-P as a lead compound.
